Clinical trial
Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic…
NCT00055718 · Herbert Irving Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00055718 |
|---|---|
| Title | Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy |
| Official title | A Pilot Study of Silymarin During Maintenance Therapy in Children With Acute Lymphoblastic Leukemia (ALL) |
| Lead sponsor | Herbert Irving Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Drug/Agent Toxicity by Tissue/Organ, Leukemia |
| Intervention type | Dietary Supplement |
| Interventions | silymarin |
| Enrollment | 50 |
| Start date | Nov 1, 2001 |
| Completion | Jan 1, 2010 |
| First posted | Mar 7, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: